{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:54:14Z","timestamp":1782975254800,"version":"3.54.5"},"reference-count":66,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Implantica"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/13696998.2023.2201063","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T13:02:08Z","timestamp":1681304528000},"page":"603-613","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease"],"prefix":"10.1080","volume":"26","author":[{"given":"Sam","family":"Harper","sequence":"first","affiliation":[{"name":"York Health Economics Consortium, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Grodzicki","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2564-1440","authenticated-orcid":false,"given":"Stuart","family":"Mealing","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Gemmill","sequence":"additional","affiliation":[{"name":"Sherwood Forest Hospitals NHS Foundation Trust, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Goldsmith","sequence":"additional","affiliation":[{"name":"Manchester Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.21037\/aoe-20-80"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30408-X"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.15.1972"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321365"},{"key":"e_1_3_7_6_1","unstructured":"National Institute for Health and Care Excellence. Clinical guideline [CG184]: gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. 2019. https:\/\/www.nice.org.uk\/guidance\/cg184"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.12.014"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-022-06541-w"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-020-07792-1"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-016-5370-3"},{"key":"e_1_3_7_11_1","unstructured":"National Institute for Health and Care Excellence. Interventional procedures guidance [IPG749]: laparoscopic insertion of a magnetic ring for gastrooesophageal reflux disease. 2023. https:\/\/www.nice.org.uk\/guidance\/ipg749"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-020-00794-9"},{"key":"e_1_3_7_13_1","unstructured":"Implantica. Implantica receives CE Mark Approval for RefluxStop\u2122 a potential Paradigm shift in the Treatment for Acid reflux. 2018. https:\/\/www.implantica.com\/media\/press-releases\/2018\/implantica-receives-ce-mark-approval-for-refluxstop-a-potential-paradigm-shift-in-the-treatment-for-acid-reflux\/"},{"key":"e_1_3_7_14_1","unstructured":"National Institute for Health and Care Excellence. Process and methods [PMG36]: NICE health technology evaluations: the manual. 2022. https:\/\/www.nice.org.uk\/process\/pmg36\/chapter\/introduction-to-health-technology-evaluation"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2576"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200725100-00003"},{"key":"e_1_3_7_17_1","unstructured":"National Institute for Health and Care Excellence (NICE). Dyspepsia and gastro-oesophageal reflux disease. Appendix H: full Health Economics Report. 2014. https:\/\/www.nice.org.uk\/guidance\/cg184\/evidence\/appendix-h-full-health-economics-report-pdf-6955335252"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220040-00005"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta12310"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811424"},{"key":"e_1_3_7_21_1","unstructured":"Implantica. RefluxStop CE mark trial - 3 year data. Data on File. 2022."},{"key":"e_1_3_7_22_1","unstructured":"Karolinska Institute. Literature review and analysis: laparoscopic Nissen Fundoplication. [unpublished]. (Version KILNF001). 2017."},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i35.6500"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.11005\/jbm.2018.25.3.141"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzaa041"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133052"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw470"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14955"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn121"},{"key":"e_1_3_7_30_1","unstructured":"Office for National Statistics (ONS). Cancer survival by NHS England Area Team- Adults diagnosed: 1997-2012 followed up to 2013. 2014. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/cancersurvivalbynhsenglandareateamadultsdiagnosed\/2014-12-16#oesophageal-cancer"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2017.10.020"},{"key":"e_1_3_7_32_1","unstructured":"NHS England. 2019\/20 National Cost Collection Data Publication. 2022. https:\/\/www.england.nhs.uk\/publication\/2019-20-national-cost-collection-data-publication\/"},{"key":"e_1_3_7_33_1","volume-title":"Unit costs of health and social care 2021","author":"Jones K","year":"2021","unstructured":"Jones K, Burns A. Unit costs of health and social care 2021. Kent: personal Social Services Research Unit (PSSRU); 2021."},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1552407"},{"key":"e_1_3_7_35_1","unstructured":"The Royal College of Surgeons of England. From innovation to adoption. Successfully spreading surgical innovation. 2014. https:\/\/www.rcseng.ac.uk\/-\/media\/files\/rcs\/library-and-publications\/non-journal-publications\/rcs_innovation_to_adoption_2014_web-(1).pdf"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7351.1448"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3058"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2015.279"},{"key":"e_1_3_7_39_1","unstructured":"Food and Drug Administration (FDA). Summary of Safety and Effectiveness Data (SSED) for LINX Reflux Management System. 2012."},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30318-3"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp12X636065"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2017.12.008"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0543-5"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3365-x"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819001559"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128004"},{"key":"e_1_3_7_47_1","unstructured":"Public Health England. Clostridium difficile infection: mandatory surveillance 2017\/18. 2018. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/724368\/CDI_summary_2018.pdf"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.179"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017739"},{"key":"e_1_3_7_50_1","unstructured":"National Institute for Health and Care Excellence. Interventional procedures guidance [IPG585]: laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease. 2017. https:\/\/www.nice.org.uk\/guidance\/ipg585"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-018-3775-0"},{"key":"e_1_3_7_52_1","unstructured":"Kind P Hardman G Macran S. UK population norms for EQ-5D: university of York. Centre for Health Economics. 1999. https:\/\/www.york.ac.uk\/che\/pdf\/DP172.pdf"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-002-8568-5"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.13"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-019-04331-9"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLE.0000000000000785"},{"key":"e_1_3_7_57_1","unstructured":"National Institute for Health and Care Excellence. British National Formulary (BNF). 2020. https:\/\/bnf.nice.org.uk\/"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-018-6038-y"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs269"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0054-0"},{"key":"e_1_3_7_61_1","unstructured":"Kidneyfailurerisk. The kidney failure risk equation. 2022. https:\/\/kidneyfailurerisk.com\/"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011805"},{"key":"e_1_3_7_63_1","unstructured":"National Institute for Health and Care Excellence (NICE). Technology appraisal guidance [TA464]: bisphosphonates for treating osteoporosis. 2017. https:\/\/www.nice.org.uk\/guidance\/ta464"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0137-0"},{"key":"e_1_3_7_65_1","unstructured":"National Institute for Health and Care Excellence. Quality standard [QS110]: Pneumonia in adults. 2016. https:\/\/www.nice.org.uk\/guidance\/qs110"},{"key":"e_1_3_7_66_1","unstructured":"National Institute for Health and Care Excellence (NICE). Technology appraisal guidance [TA378]: ramucirumab for treating advanced gastric cancer or gastro\u2013oesophageal junction adenocarcinoma previously treated with chemotherapy. 2016. https:\/\/www.nice.org.uk\/guidance\/ta378"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012977"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2023.2201063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T09:55:03Z","timestamp":1701942903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2023.2201063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/13696998.2023.2201063"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2023.2201063","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}